Public Radio Programs Discuss New Gardasil Statistics

Main Category: Cervical Cancer / HPV Vaccine
Article Date: 21 Aug 2009 - 3:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


Two public radio programs recently featured reports on a study released Wednesday examining federal vaccination statistics on Merck's Gardasil, a vaccine that protects against some strains of the human papillomavirus that can lead to cervical cancer and genital warts. The vaccine is approved for girls and young women ages nine to 26 and recommended by the Centers for Disease Control and Prevention. The study found that CDC has received reports of more than 12,000 adverse events, including 20 verified deaths, which could not be definitively linked with the vaccine. Summaries of the radio broadcasts appear below.

~ NPR's "All Things Considered": Wednesday's program included a report on the safety of the vaccine. The segment included comments from study author Barbara Slade, a medical officer in CDC's Immunization Safety Office, and Neal Halsey, a pediatrician and the director of the Institute for Vaccine Safety at Johns Hopkins University. Slade said, "It still appears that the vaccine is safe and that the benefits outweigh the risks." She added that the "benefit is that it will prevent infection with the most common types of [HPV] that cause cervical cancer." Halsey said he is "certain" the vaccine is "by far the safest thing one can do with young children today." He added, "To the best of my knowledge, there's no evidence that any" of the deaths reported in the study "have been causally related to the vaccine" (Wilson, "All Things Considered," NPR, 8/19).

~ PRI's "The Takeaway": Thursday's program included a discussion with Sheila Rothman -- a professor at Columbia University's Mailman School of Public Health who co-authored an analysis of Merck's marketing of Gardasil -- and Diane Harper, a physician and one of the leading researchers for the vaccine's clinical trials. According to "The Takeaway," Harper "has been speaking out in favor of more warnings" on adverse events associated with Gardasil. The segment also featured comments from a woman on whether she plans to have her daughter vaccinated (Hockenberry et al., "The Takeaway," PRI, 8/20).

Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.

© 2009 The Advisory Board Company. All rights reserved.

View drug information on Gardasil.


Article adapted by Medical News Today from original press release.
Visit our cervical cancer / hpv vaccine section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
National Partnership for Women & Families. "Public Radio Programs Discuss New Gardasil Statistics." Medical News Today. MediLexicon, Intl., 21 Aug. 2009. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/161425.php>

APA
National Partnership for Women & Families. (2009, August 21). "Public Radio Programs Discuss New Gardasil Statistics." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/161425.php.

Please note: If no author information is provided, the source is cited instead.


Cervical Cancer / HPV Vaccine

Most Popular Articles



Follow Our Cervical Cancer News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Cervical Cancer / HPV Vaccine Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »